在恶性瘤中研究B7-H3的进展
Shuaixiang Zhao1,2, He Zhang2, Guanning Shang1,2
1The First Clinical College, Liaoning University of Traditional Chinese Medicine, Shenyang, Liaoning, China.
Frontiers in immunology
|June 16, 2025
概括
B7同源3 (B7-H3) 是一种在瘤中发现的蛋白质,它影响癌症的进展和免疫反应. 准B7-H3对开发新癌症疗法的有希望.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 分子生物学分子生物学
背景情况:
- B7同源3 (B7-H3),也称为CD276,是B7免疫蛋白家族的新成员.
- B7-H3在正常与瘤组织中表现出不同的表达模式,与瘤进展相关.
- 它通过通过受体结合来激活或抑制免疫反应,在瘤免疫力中发挥双重作用.
研究的目的:
- 审查B7-H3在癌症进展中的结构,分布和功能.
- 总结关于B7-H3向治疗方法和临床试验的当前研究.
- 突出B7-H3在治疗恶性瘤中的治疗潜力.
主要方法:
- 关于B7-H3结构,功能和表达的文献综述.
- 分析B7-H3在免疫和非免疫癌症相关过程中的作用.
- 关于B7-H3向治疗的临床前和临床研究的摘要.
主要成果:
- B7-H3 影响瘤免疫反应和非免疫功能,如迁移,血管生成,新陈代谢和耐药性.
- 在正常和瘤组织之间存在B7-H3表达的显著差异.
- 目前正在进行的研究正在推动针对B7-H3的药物的开发.
结论:
- B7-H3 是恶性瘤进展的关键调节者.
- 针对B7-H3为各种癌症提供了显著的治疗潜力.
- 进一步的研究和临床试验对于实现B7-H3的全部临床效用至关重要.
相关概念视频
Tumor Progression
6.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.5K
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K


